The latest filing states the doubt was alleviated.
“In connection with the Company's assessment of going concern considerations in accordance with ASC 205-40, "Presentation of Financial Statements – Going Concern", as of June 30, 2026, the Company does not have sufficient liquidity to meet its working capital needs until a minimum of one year from the date of issuance of these financial statements. However, the Company completed its Initial Public Offering on August 19, 2026 which provides sufficient liquidity to meet its working capital needs until a minimum of one year from the date of issuance of these financial statements.”View the 10-Q filed Oct 1, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The closing range uses available history since Aug 27, 2026; less than a full year is stored.
Xterax Corporation II shareholders approved changing the company’s name from Karman Line Acquisition Corp. on October 19, 2026, and adopted conforming amended articles; units, shares and warrants will continue trading as XTERU, XTER and XTERW.
Karman Line Acquisition Corp. completed its initial public offering on August 19, 2026, generating $200,000,000, and has selected no business combination target. It reported net losses of $44,823 and $44,863 for the three and six months ended June 30, 2026.
Karman Line Acquisition Corp. shareholders are asked to approve changing its name to Xterax Corporation II and authorize adjournment if needed, at an October 19, 2026 meeting requiring two-thirds of votes cast for the name change.
Useful current figures from the complete screener profile.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Illustrative technical + ownership context — a signal mix, not investment advice.
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
XTER
this stock
Xterax Corp II
|
$266.88M | — | — | — | 0.0% |
|
VYLR
Vylor Inc.
|
$48.01B | — | — | — | 2.2% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$650.38M | +3.3% | — | — | 0.0% |
|
CCXI
Churchill Capital Corp XI
|
$627.18M | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Xterax Corporation II shareholders approved changing the company’s name from Karman Line Acquisition Corp. on October 19, 2026, and adopted conforming amended articles; units, shares and warrants will continue trading as XTERU, XTER and XTERW.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XTER | -0.1% | -0.3% | — | -0.2% | — |
| SPY | -2.0% | -3.2% | +1.6% | -0.2% | +10.6% |
| vs SPY | +1.9% | +2.9% | — | 0.0% | — |
